Works matching IS 13520504 AND DT 2018 AND VI 25 AND IP 11

Results: 22

New viral biomarkers for Hepatitis B: Are we able to change practice?

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1226, doi. 10.1111/jvh.12993

By:

Höner zu Siederdissen, Christoph;
Maasoumy, Benjamin;
Cornberg, Markus

Publication type:

Article

Hepatitis B surface antigen positivity during pregnancy and risk of gestational diabetes mellitus: A systematic review and meta‐analysis.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1372, doi. 10.1111/jvh.12964

By:

Tan, Jing;
Mao, Xuanyue;
Zhang, Guiting;
Wang, Wen;
Pan, Tianying;
Liu, Xinghui;
Sun, Xin

Publication type:

Article

UBE2L3, a susceptibility gene that plays oncogenic role in hepatitis B‐related hepatocellular carcinoma.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1363, doi. 10.1111/jvh.12963

By:

Liu, Yao;
Song, Ci;
Ni, Hengli;
Jiao, Weijuan;
Gan, Wenjuan;
Dong, Xiaoqiang;
Liu, Jibin;
Zhu, Liguo;
Zhai, Xiangjun;
Hu, Zhibin;
Li, Jianming

Publication type:

Article

Hepatitis B virus infection and diabetes mellitus: An adverse relationship A letter in response to Incidence and prevalence of hepatitis B in patients with diabetes mellitus in the UK: A population‐based cohort study using the UK Clinical Practice Research Datalink

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1401, doi. 10.1111/jvh.12949

By:

Kumar, R.

Publication type:

Article

Emergency departments at the crossroads of intersecting epidemics (HIV, HCV, injection drug use and opioid overdose)—Estimating HCV incidence in an urban emergency department population.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1397, doi. 10.1111/jvh.12948

By:

Hsieh, Y.‐H.;
Patel, A. V.;
Loevinsohn, G. S.;
Thomas, D. L.;
Rothman, R. E.

Publication type:

Article

Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1384, doi. 10.1111/jvh.12947

By:

Lutterkort, G. L.;
Wranke, A.;
Hengst, J.;
Yurdaydin, C.;
Stift, J.;
Bremer, B.;
Hardtke, S.;
Keskin, O.;
Idilman, R.;
Manns, M. P.;
Dienes, H. P.;
Falk, C.;
Wedemeyer, H.;
Heidrich, B.

Publication type:

Article

CD56<sup>bright</sup> natural killer cells induce HBsAg reduction via cytolysis and cccDNA decay in long‐term entecavir‐treated patients switching to peginterferon alfa‐2a.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1352, doi. 10.1111/jvh.12946

By:

Shi, A.;
Zhang, X.;
Xiao, F.;
Zhu, L.;
Yan, W.;
Han, M.;
Luo, X.;
Chen, T.;
Ning, Q.

Publication type:

Article

Epidemiology and patient characteristics of hepatitis D virus infection in the West of Scotland 2011‐2016.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1395, doi. 10.1111/jvh.12939

By:

Jackson, C.;
Gunson, R. N.;
Bradley‐Stewart, A.;
Bennett, S.;
Black, H.;
Kennedy, N.;
Bell, D. J.

Publication type:

Article

Differential expression profile of hepatic circular RNAs in chronic hepatitis B.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1341, doi. 10.1111/jvh.12944

By:

Zhou, T.‐C.;
Li, X.;
Chen, L.‐J.;
Fan, J.‐H.;
Lai, X.;
Tang, Y.;
Zhang, L.;
Wei, J.

Publication type:

Article

Real‐world outcomes of unrestricted direct‐acting antiviral treatment for hepatitis C in Australia: The South Australian statewide experience.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1287, doi. 10.1111/jvh.12943

By:

Haridy, J.;
Wigg, A.;
Muller, K.;
Ramachandran, J.;
Tilley, E.;
Waddell, V.;
Gordon, D.;
Shaw, D.;
Huynh, D.;
Stewart, J.;
Nelson, R.;
Warner, M.;
Boyd, M.;
Chinnaratha, M. A.;
Harding, D.;
Ralton, L.;
Colman, A.;
Liew, D.;
Iyngkaran, G.;
Tse, E.

Publication type:

Article

Safety and efficacy of vesatolimod (GS‐9620) in patients with chronic hepatitis B who are not currently on antiviral treatment.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1331, doi. 10.1111/jvh.12942

By:

Agarwal, K.;
Ahn, S. H.;
Elkhashab, M.;
Lau, A. H.;
Gaggar, A.;
Bulusu, A.;
Tian, X.;
Cathcart, A. L.;
Woo, J.;
Subramanian, G. M.;
Andreone, P.;
Kim, H. J.;
Chuang, W. L.;
Nguyen, M. H.

Publication type:

Article

Comparison of effectiveness and discontinuation of interferon‐free therapy for hepatitis C in prison inmates and noninmates.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1280, doi. 10.1111/jvh.12940

By:

Marco, A.;
Roget, M.;
Cervantes, M.;
Forné, M.;
Planella, R.;
Miquel, M.;
Ortiz, J.;
Navarro, M.;
Gallego, C.;
Vergara, M.;
Almada, Guido;
Casas, Meritxell;
Silva, Antonio;
Dalmau, Blai;
Guerrero, Rafael A;
Profitós, Joaquím;
Ruíz, Ana;
Sala, Montserrat;
Sarriera, Carmen;
Sastre, Ana

Publication type:

Article

Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real‐world experience study.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1298, doi. 10.1111/jvh.12945

By:

Flisiak, R.;
Janczewska, E.;
Łucejko, M.;
Karpińska, E.;
Zarębska‐Michaluk, D.;
Nazzal, K.;
Bolewska, B.;
Białkowska, J.;
Berak, H.;
Fleischer‐Stępniewska, K.;
Tomasiewicz, K.;
Karwowska, K.;
Simon, K.;
Piekarska, A.;
Tronina, O.;
Tuchendler, E.;
Garlicki, A.

Publication type:

Article

Real‐world effectiveness of elbasvir/grazoprevir In HCV‐infected patients in the US veterans affairs healthcare system.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1270, doi. 10.1111/jvh.12937

By:

Kramer, J. R.;
Puenpatom, A.;
Erickson, K. F.;
Cao, Y.;
Smith, D.;
El‐Serag, H. B.;
Kanwal, F.

Publication type:

Article

Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in London.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1260, doi. 10.1111/jvh.12936

By:

Aisyah, D. N.;
Shallcross, L.;
Hayward, A.;
Aldridge, R. W.;
Hemming, S.;
Yates, S.;
Ferenando, G.;
Possas, L.;
Garber, E.;
Watson, J. M.;
Geretti, A. M.;
McHugh, T. D.;
Lipman, M.;
Story, A.

Publication type:

Article

Switching to tenofovir vs continuing entecavir for hepatitis B virus with partial virologic response to entecavir: a randomized controlled trial.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1321, doi. 10.1111/jvh.12934

By:

Yim, H. J.;
Kim, I. H.;
Suh, S. J.;
Jung, Y. K.;
Kim, J. H.;
Seo, Y. S.;
Yeon, J. E.;
Kim, C. W.;
Kwon, S. Y.;
Park, S. H.;
Lee, M. S.;
Um, S. H.;
Byun, K. S.

Publication type:

Article

Hepatitis B virus reactivation in patients with rheumatoid arthritis: Analysis of the National Database of Japan.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1312, doi. 10.1111/jvh.12933

By:

Fujita, M.;
Sugiyama, M.;
Sato, Y.;
Nagashima, K.;
Takahashi, S.;
Mizokami, M.;
Hata, A.

Publication type:

Article

Evolution and persistence of resistance‐associated substitutions of hepatitis C virus after direct‐acting antiviral treatment failures.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1251, doi. 10.1111/jvh.12932

By:

Jeong, Y.;
Jin, B.;
Lee, H. W.;
Park, H. J.;
Park, J. Y.;
Kim, D. Y.;
Han, K.‐H.;
Ahn, S. H.;
Kim, S.

Publication type:

Article

Detection of Hepatitis B Virus DNA among Chronic and potential Occult HBV patients in resource‐limited settings by Loop‐Mediated Isothermal Amplification assay.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1306, doi. 10.1111/jvh.12931

By:

Akram, A.;
Islam, S. M. R.;
Munshi, S. U.;
Tabassum, S.

Publication type:

Article

Prevalence and predictive factors of moderate/severe liver steatosis in chronic hepatitis C (CHC) infected patients evaluated with controlled attenuation parameter (CAP).

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1244, doi. 10.1111/jvh.12930

By:

Cardoso, A. C.;
Perez, R. M.;
Figueiredo‐Mendes, C.;
Carvalho Leite, N.;
Moraes‐Coelho, H. S.;
Villela‐Nogueira, C. A.

Publication type:

Article

Evaluation of a hepatitis C clinical care coordination programme's effect on treatment initiation and cure: A surveillance‐based propensity score matching approach.

Published in:

Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1236, doi. 10.1111/jvh.12929

By:

Deming, R.;
Ford, M. M.;
Moore, M. S.;
Lim, S.;
Perumalswami, P.;
Weiss, J.;
Wyatt, B.;
Shukla, S.;
Litwin, A.;
Reynoso, S.;
Laraque, F.

Publication type:

Article

Issue Information.

Published in:: Journal of Viral Hepatitis, 2018, v. 25, n. 11, p. 1223, doi. 10.1111/jvh.12780
Publication type:: Article